PKG-I inhibition attenuates vascular endothelial growth factor-stimulated angiogenesis. (Q54652077)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20813203%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

PKG-I inhibition attenuates vascular endothelial growth factor-stimulated angiogenesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20813203%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20813203%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Andreas Papapetropoulos

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20813203%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Federica Finetti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20813203%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Vasiliki Koika

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20813203%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Zongmin Zhou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20813203%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Ioannis Vasileiadis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20813203%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Charis Roussos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20813203%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Lucia Morbidelli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20813203%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

8 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20813203%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

published in

Vascular Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20813203%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20813203%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

215-222

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20813203%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

5-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20813203%20AND%20SRC:MED&resulttype=core&format=json

cGMP-dependent protein kinase I is crucial for angiogenesis and postnatal vasculogenesis

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

cGMP-dependent protein kinase modulators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Angiogenesis in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Angiogenesis in life, disease and medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase Ialpha inhibit NO-induced cerebral dilation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Angiogenesis as a therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

The biology of VEGF and its receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

The biology of cyclic GMP-dependent protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Vascular endothelial growth factor-mediated activation of p38 is dependent upon Src and RAFTK/Pyk2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Vascular permeability, vascular hyperpermeability and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Nitric oxide and cGMP activate the Ras-MAP kinase pathway-stimulating protein tyrosine phosphorylation in rabbit aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Structure and function of cGMP-dependent protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Soluble guanylyl cyclase activation promotes angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

cGMP-dependent and -independent angiogenesis-related properties of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G/MAPK pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Sildenafil promotes ischemia-induced angiogenesis through a PKG-dependent pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Antiangiogenesis to treat cancer and intraocular neovascular disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Inhibition of cGMP-dependent protein kinase by the cell-permeable peptide DT-2 reveals a novel mechanism of vasoregulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Protein kinase signaling in the modulation of microvascular permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

VEGF signalling: integration and multi-tasking in endothelial cell biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Nitric oxide and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004

Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2010.08.004